Diabetes News
Label update for diabetes drug liraglutide to include prevention of cardiovascular events
New insulin therapy demonstrates cardiovascular safety and reduces the risk of severe hypoglycemia
Severe obesity in high-risk youth correlates directly to increased incidence of type 2 diabetes
SGLT2 inhibitors are associated with lower rates of death for patients with type 2 diabetes
New LEADER trial analysis shows reduction in cardiovascular risk in people with type 2 diabetes
Increased heart problems in women with diabetes
Five million people at risk of developing diabetes
Minority patients under-represented in diabetes trials
Study sheds light on importance of fat stem cells in understanding risk of diabetes
Gaps in patients’ knowledge of diabetes side effects
- 1
- 2